Rapid Cardiac Markers
Rapid detection of troponin, CK-MB or myoglobin in a blood specimen can be the difference between life and death in cases of myocardial infarction. Given the widespread occurrence of heart attacks among increasingly heavy populations across developed and developing nations – this is a valuable (in every sense of the word) technology to get involved in. Find the latest and most informative reports below.
Preventative healthcare, or preventive healthcare, accounts for measures that are adopted for disease prevention rather than disease treatment. Millions of people die preventable deaths every year and...
EUR 6226USD 6,500GBP 4,496AUD 8,644JPY 800,132SEK 58 075CHF 6 405CAD 8,235
U.S. Cardiac Biomarkers Diagnostics Markets
This research service analyzes the market for cardiac biomarkers within the United States The United States market was divided into the acute myocardial infarction diagnostics and congestive heart failure...
EUR 5747USD 6,000GBP 4,150AUD 7,979JPY 738,583SEK 53 608CHF 5 913CAD 7,602
Successful Management of Heart Failure Patients: Multidisciplinary Approach to Reducing Readmissions
Approximately 5 million people in the United States have heart failure, with 550,000 new cases diagnosed annually The condition is the number one cause for hospitalization among the elderly; one fifth...
EUR 93USD 97GBP 67AUD 129JPY 11,940SEK 867CHF 96CAD 123